Education
About Us
Working with TipRanks
Follow Us
Devonian Health Group, Inc. (TSE:GSD)
:GSD
GSD Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.08 - C$0.35
Previous CloseN/A
VolumeN/A
Average Volume (3M)8.30K
Market Cap
C$37.06M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)4.76M
Price to Earnings (P/E)―
Beta1.28
Next Earnings
Jun 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding148,222,530
10 Day Avg. Volume6,998
30 Day Avg. Volume8,297
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.08
Price to Cash Flow (P/CF)28.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Devonian Health Group, Inc. News
PremiumCompany Announcements
Devonian Health Group Announces Key Approvals at Annual Shareholder Meeting
PremiumCompany Announcements
Devonian Health Group Files Patent for Thykamine™ as Antifibrotic Agent
PremiumCompany Announcements
Devonian Health Group Files Patent for Thykamine™ in Liver Disease Treatment
PremiumCompany Announcements
Devonian Health Faces Revenue Impact as Dexlansoprazole License Ends
PremiumCompany Announcements
Devonian’s Thykamine™ Shows Superior Anti-Inflammatory Potency in Study
PremiumCompany Announcements
Devonian Health Group Appoints New CFO to Drive Growth
PremiumCompany Announcements
Devonian Health Sees Revenue Surge Amid Stock Option Grants---
GSD FAQ
What was Devonian Health Group, Inc.’s price range in the past 12 months?
Devonian Health Group, Inc. lowest stock price was C$0.07 and its highest was C$0.35 in the past 12 months.
What is Devonian Health Group, Inc.’s market cap?
Devonian Health Group, Inc.’s market cap is C$37.06M.
When is Devonian Health Group, Inc.’s upcoming earnings report date?
Devonian Health Group, Inc.’s upcoming earnings report date is Jun 25, 2025 which is in 85 days.
How were Devonian Health Group, Inc.’s earnings last quarter?
Currently, no data Available
Is Devonian Health Group, Inc. overvalued?
According to Wall Street analysts Devonian Health Group, Inc.’s price is currently Overvalued.
Does Devonian Health Group, Inc. pay dividends?
Devonian Health Group, Inc. does not currently pay dividends.
What is Devonian Health Group, Inc.’s EPS estimate?
Devonian Health Group, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Devonian Health Group, Inc. have?
Devonian Health Group, Inc. has 148,222,530 shares outstanding.
What happened to Devonian Health Group, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Devonian Health Group, Inc.?
Currently, no hedge funds are holding shares in TSE:GSD
---
Company Description
Devonian Health Group, Inc.
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It is intended to develop prescription botanical drugs which could be from plant materials, algae, macroscopic fungi, and combinations thereof. The company's technology platform, The Supra Molecular Complex Extraction, and Stabilization Technology provide a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. The products of the group include botanical pharmaceuticals, Thykamine; and derma-cosmeceutical product, Purgenesis.
---
Technical Analysis
---